Medra is structurally reforming life sciences with 'Physical AI' - autonomous robotic systems for the laboratory. The company's platform automates wet lab protocols, using computer vision to monitor experiments and robotics to execute them with high precision. Medra is positioned to accelerate drug discovery by removing the manual bottleneck of bench science, enabling 'self-driving' laboratories. This technology addresses critical bottlenecks in computational efficiency and data governance, supporting broader industrial automation.